Clinical Implications of Low Body Mass Index on Endovascular Lower Extremity Revascularization

被引:0
|
作者
Rodriguez, Paula Pinto [1 ]
Alameddine, Dana [1 ]
Huttler, Joshua [2 ]
Damara, Fachreza Aryo [1 ]
Slade, Martin [3 ]
Cardella, Jonathan [1 ]
Guzman, Raul J. [1 ]
Chaar, Cassius Iyad Ochoa [1 ]
机构
[1] Yale Univ, Sch Med, Div Vasc Surg & Endovasc Therapy, 333 Cedar St, New Haven, CT 06510 USA
[2] Yale Univ, Sch Med, New Haven, CT USA
[3] Yale Univ, Sch Med, Yale Occupat & Environm Med Program, New Haven, CT USA
关键词
OBESITY PARADOX; ARTERY-DISEASE; MORTALITY; INSUFFICIENCY; SURVIVAL; JAPANESE; COHORT; IMPACT; RISK;
D O I
10.1016/j.avsg.2024.02.031
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: The epidemic of obesity and associated cardiovascular morbidity continues to grow, attracting public attention and healthcare resources. However, the impact of malnutrition and being underweight continues to be overshadowed by obesity, especially in patients with peripheral arterial disease (PAD). This study assesses the characteristics and outcomes of patients with low body mass index (BMI < 18.5) compared to patients with nonobese BMI undergoing peripheral vascular interventions (PVI). Methods: A retrospective analysis of patients undergoing PVI due to PAD registered in the Vascular Quality Initiative database. Patients were categorized into underweight (BMI < 18.5) and nonobese BMI (BMI = 18.5e30). Patients in both groups were matched 3:1 for baseline dewas done for long-term outcomes. Results: A total of 337,926 patients underwent PVI, of whom 12,935 (4%) were underweight, 215,728 (64%) were nonobese, and 109,263 (32%) were obese. Underweight patients were more likely to be older, female, smokers, with chronic obstructive pulmonary disorder, and more likely to present with chronic limb-threatening ischemia than nonobese patients. After propensity matching, there were 18,047 nonobese patients and 6,031 underweight patients. There were no significant differences in matched characteristics. Perioperatively, underweight patients were more likely to require a longer hospital length of stay. Underweight patients had statistically significantly higher 30-day mortality compared to patients with nonobese BMI (3% vs. 1.6%, P < 0.001) and a higher rate of thrombotic complications. As for long-term outcomes, underweight patients had a higher rate of reintervention (20% vs. 18%, P < 0.001) and major adverse limb events (27% vs. 22%, P < 0.001). The 4-year rate of amputation-free survival was significantly lower in underweight patients (70% vs. 82%, P < 0.001), and the 2-year freedom from major amputation (90% vs. 94%, P < 0.001) showed similar trends with worse outcomes in patients who were underweight. Conclusions: Underweight patients with PAD are disproportionally more likely to be African American, females, and smokers and suffer worse outcomes after PVI than PAD patients with nonobese BMI. When possible, increased scrutiny and optimization of nutrition and other factors contributing to low BMI should be addressed prior to PVI.
引用
收藏
页码:350 / 359
页数:10
相关论文
共 50 条
  • [21] Predicting Outcomes Following Lower Extremity Endovascular Revascularization Using Machine Learning
    Li, Ben
    Aljabri, Badr
    Verma, Raj
    Beaton, Derek
    Hussain, Mohamad A.
    Lee, Douglas S.
    Wijeysundera, Duminda N.
    de Mestral, Charles
    Mamdani, Muhammad
    Al-Omran, Mohammed
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (09):
  • [22] Comparative effectiveness of endovascular versus surgical revascularization for acute lower extremity ischemia
    Taha, Ashraf G.
    Byrne, Raphael M.
    Avgerinos, Efthymios D.
    Marone, Luke K.
    Makaroun, Michel S.
    Chaer, Rabih A.
    [J]. JOURNAL OF VASCULAR SURGERY, 2015, 61 (01) : 147 - 154
  • [23] Cost of Open and Endovascular Infrainguinal Lower Extremity Revascularization for CLTI in the Medicare Population
    Satam, Keyuree
    Zheng, Xinyan
    Mao, Jialin
    Guzman, Raul J.
    Goodney, Philip
    Chaar, Cassius Iyad Ochoa
    [J]. JOURNAL OF VASCULAR SURGERY, 2023, 77 (06) : E67 - E68
  • [24] Dual-Antiplatelet Therapy Prevails over Low-Dose Rivaroxaban Following Lower Extremity Endovascular Revascularization
    Jarosinski, Marissa
    Reitz, Katherine M.
    Khamzina, Yekaterina
    Sridharan, Natalie D.
    Liang, Nathan L.
    Tzeng, Edith
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2023, 237 (05) : S591 - S591
  • [25] Lower extremity revascularization via endovascular and surgical approaches: A systematic review with emphasis on combined inflow and outflow revascularization
    Mustapha, Jihad A.
    Anose, Bynthia M.
    Martinsen, Brad J.
    Pliagas, George
    Ricotta, Joseph
    Boyes, Christopher W.
    Lee, Michael S.
    Saab, Fadi
    Adams, George
    [J]. SAGE OPEN MEDICINE, 2020, 8
  • [26] Analysis of the retrograde tibial artery approach in lower extremity revascularization in an office endovascular center
    Lai, Samuel H.
    Fenlon, Jordan
    Roush, Benjamin B.
    Munn, John
    Rummel, Mark
    Johnston, Daniel
    Longton, Chris
    Jain, Krishna M.
    [J]. JOURNAL OF VASCULAR SURGERY, 2019, 70 (01) : 157 - 165
  • [28] Improving Lower Extremity Functioning in Peripheral Artery Disease Exercise, Endovascular Revascularization, or Both?
    McDermott, MaryMcGrae
    Kibbe, Melina R.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (07): : 689 - 690
  • [29] Role of Sex in Determining Treatment Type for Patients Undergoing Endovascular Lower Extremity Revascularization
    Ramkumar, Niveditta
    Suckow, Bjoern D.
    Brown, Jeremiah R.
    Sedrakyan, Art
    MacKenzie, Todd
    Stone, David H.
    Cronenwett, Jack L.
    Goodney, Philip P.
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2019, 8 (17):
  • [30] Endovascular versus Surgical Lower Extremity Revascularization among Patients with Chronic Kidney Disease
    Chen, Qingzheng
    Han, Jialin
    Parvathinathan, Gomathy
    Ross, Elsie
    Stedman, Margaret R.
    Chang, Tara I.
    [J]. INTERNATIONAL JOURNAL OF NEPHROLOGY, 2023, 2023